• Breast cancer: Oral SERDs in ER+ BC. Part 3 - Rare cases & treatment challenges

  • Dec 6 2023
  • Duración: 26 m
  • Podcast

Breast cancer: Oral SERDs in ER+ BC. Part 3 - Rare cases & treatment challenges

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this final episode, the experts discuss two patient case studies with oral SERDs (oral selective estrogen receptor degraders) and a novel therapy for ER+/HER2- advanced or metastatic breast cancer. Each patient presents unique and rare situations that shed light on the challenges confronting healthcare professionals and patients alike. They discuss the most up-to-date data and strategies for optimising treatment selection in each individual case.

    This podcast is a conversation between two independent experts: Dr. Rena Callahan an Associate Clinical Professor of Hematology Oncology at University of California, Los Angeles David Geffen School of Medicine and Dr. Shaheenah Dawood, a consultant medical oncologist and professor of oncology at Mediclinic City Hospital, United Arab Emirates, Dubai.
    Más Menos
Más Menos
activate_Holiday_promo_in_buybox_DT_T2

Lo que los oyentes dicen sobre Breast cancer: Oral SERDs in ER+ BC. Part 3 - Rare cases & treatment challenges

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles